-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Femasys (NASDAQ:FEMY) Stock Price Down 0.8%
Femasys (NASDAQ:FEMY) Stock Price Down 0.8%
Femasys Inc. (NASDAQ:FEMY – Get Rating)'s stock price fell 0.8% during trading on Tuesday . The company traded as low as $1.18 and last traded at $1.21. 2,561 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 8,797 shares. The stock had previously closed at $1.22.
Analyst Ratings Changes
FEMY has been the subject of a number of recent analyst reports. Chardan Capital dropped their price target on shares of Femasys from $15.00 to $12.00 and set a "buy" rating for the company in a research note on Friday, November 11th. HC Wainwright dropped their price target on shares of Femasys from $8.00 to $5.00 and set a "buy" rating for the company in a research note on Thursday, October 20th.
Get Femasys alerts:Femasys Stock Performance
The company has a market capitalization of $14.30 million, a PE ratio of -1.53 and a beta of -0.23. The company has a current ratio of 9.56, a quick ratio of 9.37 and a debt-to-equity ratio of 0.01. The firm's 50-day simple moving average is $1.10 and its 200-day simple moving average is $1.41.
Femasys (NASDAQ:FEMY – Get Rating) last released its quarterly earnings data on Thursday, November 10th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.23) by ($0.02). The company had revenue of $0.35 million during the quarter, compared to analysts' expectations of $0.40 million. Femasys had a negative net margin of 886.22% and a negative return on equity of 48.96%. On average, research analysts predict that Femasys Inc. will post -0.98 earnings per share for the current year.Institutional Investors Weigh In On Femasys
Several large investors have recently added to or reduced their stakes in the stock. Cetera Advisor Networks LLC bought a new stake in shares of Femasys in the 1st quarter valued at about $27,000. Virtu Financial LLC bought a new stake in shares of Femasys in the 2nd quarter valued at about $39,000. HB Wealth Management LLC bought a new stake in shares of Femasys in the 4th quarter valued at about $49,000. LPL Financial LLC bought a new stake in shares of Femasys in the 2nd quarter valued at about $51,000. Finally, Cambridge Investment Research Advisors Inc. bought a new stake in shares of Femasys in the 1st quarter valued at about $68,000. 7.49% of the stock is owned by hedge funds and other institutional investors.
About Femasys
(Get Rating)
Femasys Inc, a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing.
See Also
- Get a free copy of the StockNews.com research report on Femasys (FEMY)
- Verizon, Charter Trend Higher In Past Month: Are They Buys Now?
- Dividend King Sysco: Buying On The Dip
- Is the 1,600% Rise in Genius Group Stock Justified?
- After Further Review, Investors Liked Exxon Mobil's Earnings
- Will Caterpillar Dig Its Way To Another Buying Opportunity?
Receive News & Ratings for Femasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Femasys and related companies with MarketBeat.com's FREE daily email newsletter.
Femasys Inc. (NASDAQ:FEMY – Get Rating)'s stock price fell 0.8% during trading on Tuesday . The company traded as low as $1.18 and last traded at $1.21. 2,561 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 8,797 shares. The stock had previously closed at $1.22.
週二交易期間，飛馬西股份有限公司（NASDAQ：FEMY-獲得評級）的股價下跌了 0.8％。該公司的交易價格低至 1.18 美元，最後交易價為 1.21 美元。2,561 股在中間交易期間變手，較 8,797 股的平均交易量下降了 71%。該股票之前已收盤 1.22 美元。
Analyst Ratings Changes
分析師等級變更
FEMY has been the subject of a number of recent analyst reports. Chardan Capital dropped their price target on shares of Femasys from $15.00 to $12.00 and set a "buy" rating for the company in a research note on Friday, November 11th. HC Wainwright dropped their price target on shares of Femasys from $8.00 to $5.00 and set a "buy" rating for the company in a research note on Thursday, October 20th.
FEMY 一直是最近一些分析師報告的主題。Chardan Capital 於 11 月 11 日（星期五）的研究報告中，將 Femys 股票的目標價格從 15.00 美元降至 12.00 美元，並為該公司設定了「買入」評級。韋賴特在 10 月 20 日（星期四）的一份研究報告中，HC Wainwright 將其對 Femys 股票的目標價格從 8.00 美元降至 5.00 美元，並為該公司設定了「買入」評級。
Femasys Stock Performance
女性股票表現
The company has a market capitalization of $14.30 million, a PE ratio of -1.53 and a beta of -0.23. The company has a current ratio of 9.56, a quick ratio of 9.37 and a debt-to-equity ratio of 0.01. The firm's 50-day simple moving average is $1.10 and its 200-day simple moving average is $1.41.
該公司的市值為 1430 萬美元，私募股權比率為 -1.53，測試版為 -0.23。該公司的流動比率為 9.56，快速比率為 9.37，債務與權益比率為 0.01。該公司的 50 天簡單移動平均線為 1.10 美元，其 200 天的簡單移動平均線為 1.41 美元。
Institutional Investors Weigh In On Femasys
機構投資者權衡女性
Several large investors have recently added to or reduced their stakes in the stock. Cetera Advisor Networks LLC bought a new stake in shares of Femasys in the 1st quarter valued at about $27,000. Virtu Financial LLC bought a new stake in shares of Femasys in the 2nd quarter valued at about $39,000. HB Wealth Management LLC bought a new stake in shares of Femasys in the 4th quarter valued at about $49,000. LPL Financial LLC bought a new stake in shares of Femasys in the 2nd quarter valued at about $51,000. Finally, Cambridge Investment Research Advisors Inc. bought a new stake in shares of Femasys in the 1st quarter valued at about $68,000. 7.49% of the stock is owned by hedge funds and other institutional investors.
一些大型投資者最近增加或減少了他們在股票中的股份。西泰拉顧問網絡有限責任公司在第一季度購買了 Femasys 股份的新股份，價值約為 27,000 美元。維圖金融有限責任公司在第二季度購買了 Femasys 股份的新股份，價值約為 39,000 美元。HB 財富管理有限責任公司在第四季度購買了 Femys 股份的新股份，價值約為 49,000 美元。LPL 金融有限責任公司在第二季度購買了費馬斯股份的新股份，價值約為 $51,000。最後，劍橋投資研究顧問公司在第一季度購買了 Femasys 股份的新股份，價值約為 68,000 美元。7.49％ 的股票由對沖基金和其他機構投資者擁有。
About Femasys
關於飛馬思
(Get Rating)
(取得評分)
Femasys Inc, a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing.
Femasys Inc 是一家生物醫學公司，專注於美國女性醫療保健市場。該公司開發永久性避孕解決方案，例如 Fembloc 和 FemCHEC；人工授精解決方案 FemaSeed；子宮頸切除術活檢裝置 FemCerv；以及支援子宮內膜癌檢測測試的子宮內膜抽樣產品候選產品 Femeem。
See Also
另請參閱
- Get a free copy of the StockNews.com research report on Femasys (FEMY)
- Verizon, Charter Trend Higher In Past Month: Are They Buys Now?
- Dividend King Sysco: Buying On The Dip
- Is the 1,600% Rise in Genius Group Stock Justified?
- After Further Review, Investors Liked Exxon Mobil's Earnings
- Will Caterpillar Dig Its Way To Another Buying Opportunity?
- 免費獲取有關 FEMY 的股票新聞網研究報告
- Verizon 公司, 憲章趨勢在過去一個月較高:他們現在買?
- 股息國王塞斯科：在下跌的購買
- 天才集團股票上漲 1,600% 是否合理？
- 經過進一步審查，投資者喜歡埃克森美孚的收益
- 卡特彼勒會挖掘其方式到另一個購買機會嗎？
Receive News & Ratings for Femasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Femasys and related companies with MarketBeat.com's FREE daily email newsletter.
接收《女性日報》的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件時事通訊接收 Femasys 和相關公司的最新新聞和分析師評級的簡要每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧